Showing results (431-440 of 661) with videos related to
Sort By:
Pageof 67
The Journal of Thoracic and Cardiovascular Surgery|March 11, 2008
Bleeding in cardiac surgery: the use of aprotinin does not affect survivalDomenico Pagano, Neil J Howell, Nick Freemantle, et al.Nature Communications|November 25, 2024
HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01Salvatore Siena, Kanwal Raghav, Toshiki Masuishi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2018
CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric CancerYelena Y Janjigian, Johanna Bendell, Emiliano Calvo, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 14, 2018
Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032Neal Ready, Anna F Farago, Filippo de Braud, et al.ESMO Open|August 21, 2020
Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: patient-reported outcomes across two randomised clinical trialsAndrew X Zhu, Ryan D Nipp, Richard S Finn, et al.The Lancet. Oncology|February 18, 2017
Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trialRobert Glynne-Jones, David Sebag-Montefiore, Helen M Meadows, et al.British Journal of Haematology|July 5, 2020
FDG-PET/CT after two cycles of R-CHOP in DLBCL predicts complete remission but has limited value in identifying patients with poor outcome - final result of a UK National Cancer Research Institute prospective studyN George Mikhaeel, David Cunningham, Nicholas Counsell, et al.Journal of the American Heart Association|May 22, 2016
Death and Emergency Readmission of Infants Discharged After Interventions for Congenital Heart Disease: A National Study of 7643 Infants to Inform Service ImprovementSonya Crowe, Deborah A Ridout, Rachel Knowles, et al.Pathology, Research and Practice|January 22, 2025
Intra-patient comparison of microarchitecture of tumour negative lymph nodes from oesophageal cancer patients - Results from the MRC Oe02 trialMaximilian Kloft, Elzbieta Budginaite, Sander M J van Kuijk, et al.Journal of the National Cancer Institute|October 30, 2012
Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancerArnaud D Roth, Mauro Delorenzi, Sabine Tejpar, et al.Pageof 67